349 related articles for article (PubMed ID: 30101408)
1. Epithelial-stromal crosstalk and fibrosis in eosinophilic esophagitis.
Muir AB; Wang JX; Nakagawa H
J Gastroenterol; 2019 Jan; 54(1):10-18. PubMed ID: 30101408
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-Fibroblast Crosstalk in Eosinophilic Esophagitis.
Muir AB; Karakasheva TA; Whelan KA
Cell Mol Gastroenterol Hepatol; 2024; 17(5):713-718. PubMed ID: 38316214
[TBL] [Abstract][Full Text] [Related]
3. Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis.
Abu-Sultaneh SM; Durst P; Maynard V; Elitsur Y
Dig Dis Sci; 2011 Jan; 56(1):97-102. PubMed ID: 20458625
[TBL] [Abstract][Full Text] [Related]
4. Eosinophils in Eosinophilic Esophagitis: The Road to Fibrostenosis is Paved With Good Intentions.
Doyle AD; Masuda MY; Kita H; Wright BL
Front Immunol; 2020; 11():603295. PubMed ID: 33335531
[TBL] [Abstract][Full Text] [Related]
5. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of esophageal subepithelial activity in eosinophilic esophagitis.
Hirano I
J Gastroenterol; 2020 Mar; 55(3):249-260. PubMed ID: 31515617
[TBL] [Abstract][Full Text] [Related]
7. Obtaining adequate lamina propria for subepithelial fibrosis evaluation in pediatric eosinophilic esophagitis.
Wang J; Park JY; Huang R; Souza RF; Spechler SJ; Cheng E
Gastrointest Endosc; 2018 May; 87(5):1207-1214.e3. PubMed ID: 29309779
[TBL] [Abstract][Full Text] [Related]
8. TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis.
Collison AM; Sokulsky LA; Sherrill JD; Nightingale S; Hatchwell L; Talley NJ; Walker MM; Rothenberg ME; Mattes J
J Allergy Clin Immunol; 2015 Oct; 136(4):971-82. PubMed ID: 25981737
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilic esophagitis: an immune-mediated esophageal disease.
Weinbrand-Goichberg J; Segal I; Ovadia A; Levine A; Dalal I
Immunol Res; 2013 Jul; 56(2-3):249-60. PubMed ID: 23579771
[TBL] [Abstract][Full Text] [Related]
10. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.
Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C
Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052
[TBL] [Abstract][Full Text] [Related]
11. Abnormal Responses to Local Esophageal Food Allergen Injections in Adult Patients With Eosinophilic Esophagitis.
Warners MJ; Terreehorst I; van den Wijngaard RM; Akkerdaas J; van Esch BCAM; van Ree R; Versteeg SA; Smout AJPM; Bredenoord AJ
Gastroenterology; 2018 Jan; 154(1):57-60.e2. PubMed ID: 28870530
[TBL] [Abstract][Full Text] [Related]
12. Esophageal remodeling in eosinophilic esophagitis.
Shaker A
Curr Opin Gastroenterol; 2024 Jul; 40(4):291-298. PubMed ID: 38661722
[TBL] [Abstract][Full Text] [Related]
13. Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis.
Rajavelu P; Rayapudi M; Moffitt M; Mishra A; Mishra A
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(7):G645-54. PubMed ID: 22207581
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
[TBL] [Abstract][Full Text] [Related]
15. Targeting AMCase reduces esophageal eosinophilic inflammation and remodeling in a mouse model of egg induced eosinophilic esophagitis.
Cho JY; Rosenthal P; Miller M; Pham A; Aceves S; Sakuda S; Broide DH
Int Immunopharmacol; 2014 Jan; 18(1):35-42. PubMed ID: 24239745
[TBL] [Abstract][Full Text] [Related]
16. Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.
Masuda MY; Pyon GC; Luo H; LeSuer WE; Putikova A; Dao A; Ortiz DR; Schulze AR; Fritz N; Kobayashi T; Iijima K; Klein-Szanto AJ; Shimonosono M; Flashner S; Morimoto M; Pai RK; Rank MA; Nakagawa H; Kita H; Wright BL; Doyle AD
J Allergy Clin Immunol; 2024 May; 153(5):1355-1368. PubMed ID: 38310974
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the pathological understanding of eosinophilic esophagitis.
Cianferoni A; Spergel JM; Muir A
Expert Rev Gastroenterol Hepatol; 2015; 9(12):1501-10. PubMed ID: 26470602
[TBL] [Abstract][Full Text] [Related]
18. Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?
Ko E; Chehade M
Clin Rev Allergy Immunol; 2018 Oct; 55(2):205-216. PubMed ID: 29372536
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic Esophagitis: Pathophysiology and Definition.
Clayton F; Peterson K
Gastrointest Endosc Clin N Am; 2018 Jan; 28(1):1-14. PubMed ID: 29129294
[TBL] [Abstract][Full Text] [Related]
20. Disodium cromoglycate treatment reduces T
Silva FMCE; de Oliveira EE; Ambrósio MGE; Ayupe MC; de Souza VP; Menegati LM; Reis DRL; Machado MA; Macedo GC; Ferreira AP
Int Immunopharmacol; 2020 Jun; 83():106422. PubMed ID: 32251959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
